The Valley Desk

NCT02847559 · Interventional trial

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Overall registry status Completed

Phase 2

Conditions Anaplastic (Malignant) Meningioma, Atypical Meningioma, Grade II Meningioma, Grade III Meningioma, Recurrent Meningioma, Supratentorial Meningioma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov